MAGE-B2 antibody
Principal name
MAGE-B2 antibody
Alternative names for MAGE-B2 antibody
Melanoma-associated antigen B2, MAGEB2, Cancer/testis antigen 3.2, DSS-AHC critical interval MAGE superfamily 6, MAGE XP-2 antigen
SwissProt ID
O15479 (Human)
Gene ID
4113 (MAGEB2)
Ncbi ID
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Paraffin Sections (P), ELISA (detection) (E(detection)), Western blot / Immunoblot (WB)
Background of MAGE-B2 antibody
- Kit Component:
- - KN205338G1, MAGEB2 gRNA vector 1 in pCas-Guide vector
- KN205338G2, MAGEB2 gRNA vector 2 in pCas-Guide vector
- KN205338D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Formalin-fixed and paraffin-embedded human cancer tissue reacted with MAGEB2 polyclonal antibody ( Cat # PAB4752 ) , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry ; clinical relevance has not been evaluated. BC = breast carcinoma.
Western Blot analysis of MAGEB2 expression in transfected 293T cell line (H00004113-T01) by MAGEB2 MaxPab polyclonal antibody.Lane 1: MAGEB2 transfected lysate(35.09 KDa).Lane 2: Non-transfected lysate.
Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining.
Western blot analysis of MAGEB2(arrow) using rabbit polyclonal MAGEB2 Antibody. 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected with the MAGEB2 gene (Lane 2)
Human kidney; WB Suggested Anti-MAGEB2 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: Human kidney; MAGEB2 antibody - N-terminal region (ARP56336_P050) in Human kidney cells using Western Blot
Human Placenta; WB Suggested Anti-MAGEB2 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: Human Placenta; MAGEB2 antibody - N-terminal region (ARP56337_P050) in Human Placenta cells using Western Blot
Anti-MAGEB2 antibody IHC of human testis. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 20 ug/ml.
WB Suggested Anti-MAGEB2 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:312500; Positive Control: Human kidney
WB Suggested Anti-MAGEB2 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:62500; Positive Control: Human Placenta
The image on the left is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using (MAGEB2 Antibody) at dilution 1/40, on the right is treated with synthetic peptide. (Original magnification: ×200)
The image on the left is immunohistochemistry of paraffin-embedded Human ovarian cancer tissue using (MAGEB2 Antibody) at dilution 1/40, on the right is treated with synthetic peptide. (Original magnification: ×200)
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP305338 | MAGE-B2 |
||||
| Recombinant protein of human melanoma antigen family B, 2 (MAGEB2) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
